Michael B. A. Oldstone

Michael B. A. Oldstone's AcademicInfluence.com Rankings

Biology

#2328

World Rank

#3710

Historical Rank

#1048

USA Rank

Immunology

#78

World Rank

#84

Historical Rank

#28

USA Rank

biology Degrees

Download Badge

Biology

Why Is Michael B. A. Oldstone Influential?

(Suggest an Edit or Addition)

(See a Problem?)

Michael B. A. Oldstone's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

Virus-specific CD8+ cytotoxic T-lymphocyte activity associated with control of viremia in primary human immunodeficiency virus type 1 infection (1994) (2011)
Antiviral pressure exerted by HIV-l-specific cytotoxic T lymphocytes (CTLs) during primary infection demonstrated by rapid selection of CTL escape virus (1997) (1339)
Cellular localization of human immunodeficiency virus infection within the brains of acquired immune deficiency syndrome patients. (1986) (1238)
Neurologic disease induced in transgenic mice by cerebral overexpression of interleukin 6. (1993) (986)
Interleukin-10 determines viral clearance or persistence in vivo (2006) (948)
TAM Receptors Are Pleiotropic Inhibitors of the Innate Immune Response (2007) (904)
Selection of genetic variants of lymphocytic choriomeningitis virus in spleens of persistently infected mice. Role in suppression of cytotoxic T lymphocyte response and viral persistence (1984) (836)
Virus infection triggers insulin-dependent diabetes mellitus in a transgenic model: Role of anti-self (virus) immune response (1991) (824)
Differential regulation of antiviral T-cell immunity results in stable CD8+ but declining CD4+ T-cell memory (2001) (677)
Identification of alpha-dystroglycan as a receptor for lymphocytic choriomeningitis virus and Lassa fever virus. (1998) (672)
Persistent LCMV Infection Is Controlled by Blockade of Type I Interferon Signaling (2013) (668)
Anchorless Prion Protein Results in Infectious Amyloid Disease Without Clinical Scrapie (2005) (619)
Molecular mimicry and immune‐mediated diseases (1998) (591)
Endothelial Cells Are Central Orchestrators of Cytokine Amplification during Influenza Virus Infection (2011) (591)
The virology and immunobiology of lymphocytic choriomeningitis virus infection. (1980) (573)
Cytomegalovirus infects human lymphocytes and monocytes: virus expression is restricted to immediate-early gene products. (1984) (404)
Does Toll-like receptor 3 play a biological role in virus infections? (2004) (388)
Cross-Linking Cellular Prion Protein Triggers Neuronal Apoptosis in Vivo (2004) (367)
Detection of human cytomegalovirus in peripheral blood lymphocytes in a natural infection. (1985) (349)
How virus induces a rapid or slow onset insulin-dependent diabetes mellitus in a transgenic model. (1994) (340)
CD40L-deficient mice show deficits in antiviral immunity and have an impaired memory CD8+ CTL response (1996) (337)
CD4-deficient mice have reduced levels of memory cytotoxic T lymphocytes after immunization and show diminished resistance to subsequent virus challenge (1996) (325)
O-Mannosyl Phosphorylation of Alpha-Dystroglycan Is Required for Laminin Binding (2010) (323)
Virus-induced immunosuppression: immune system-mediated destruction of virus-infected dendritic cells results in generalized immune suppression (1995) (316)
Biology of cloned cytotoxic T lymphocytes specific for lymphocytic choriomeningitis virus: clearance of virus in vivo (1984) (313)
Viral persistence in neurons explained by lack of major histocompatibility class I expression. (1991) (307)
Immunosuppression and Resultant Viral Persistence by Specific Viral Targeting of Dendritic Cells (2000) (302)
PATHOGENESIS OF CHRONIC DISEASE ASSOCIATED WITH PERSISTENT LYMPHOCYTIC CHORIOMENINGITIS VIRAL INFECTION (1969) (283)
Molecular Recognition by LARGE Is Essential for Expression of Functional Dystroglycan (2004) (260)
Genomic and biological variation among commonly used lymphocytic choriomeningitis virus strains. (1983) (258)
Fine mapping of an immunodominant domain in the transmembrane glycoprotein of human immunodeficiency virus (1987) (244)
A dystroglycan mutation associated with limb-girdle muscular dystrophy. (2011) (240)
Molecular mimicry: frequency of reactivity of monoclonal antiviral antibodies with normal tissues (1986) (234)
Intrinsic Functional Dysregulation of CD4 T Cells Occurs Rapidly following Persistent Viral Infection (2005) (230)
Lysis of RNA tumor viruses by human serum: direct antibody-independent triggering of the classical complement pathway (1976) (226)
IL-7 regulates basal homeostatic proliferation of antiviral CD4+T cell memory. (2004) (221)
Prevention of type I diabetes in nonobese diabetic mice by virus infection. (1988) (221)
NP and L Proteins of Lymphocytic Choriomeningitis Virus (LCMV) Are Sufficient for Efficient Transcription and Replication of LCMV Genomic RNA Analogs (2000) (219)
Interferon-γ Is Essential for Destruction of β Cells and Development of Insulin-dependent Diabetes Mellitus (1997) (219)
Viruses evade the immune system through type I interferon-mediated STAT2-dependent, but STAT1-independent, signaling. (2005) (216)
Concepts in Viral Pathogenesis II (1986) (216)
Pathogenesis of of cytomegalovirus infection. I. Activation of virus from bone marrow-derived lymphocytes by in vitro allogenic reaction (1975) (216)
Protective immunity and susceptibility to infectious diseases: lessons from the 1918 influenza pandemic (2007) (215)
Suppression of cytokine storm with a sphingosine analog provides protection against pathogenic influenza virus (2011) (214)
IL-10 and PD-L1 operate through distinct pathways to suppress T-cell activity during persistent viral infection (2008) (213)
Astrocyte‐specific expression of hamster prion protein (PrP) renders PrP knockout mice susceptible to hamster scrapie (1997) (213)
Viral cross talk: intracellular inactivation of the hepatitis B virus during an unrelated viral infection of the liver. (1996) (210)
Cytoimitiunotherapy for persistent virus infection reveals a unique clearance pattern from the central nervous system (1986) (208)
Sequence homology and immunologic cross-reactivity of human cytomegalovirus with HLA-DR beta chain: a means for graft rejection and immunosuppression (1988) (203)
Vesicular stomatitis virus glycoprotein G activates a specific antiviral Toll-like receptor 4-dependent pathway. (2007) (203)
Bone marrow plasmacytoid dendritic cells can differentiate into myeloid dendritic cells upon virus infection (2004) (202)
Molecular basis of viral persistence: a single amino acid change in the glycoprotein of lymphocytic choriomeningitis virus is associated with suppression of the antiviral cytotoxic T-lymphocyte response and establishment of persistence (1991) (201)
Primary demyelination in transgenic mice expressing interferon-γ (1997) (196)
Biology and pathogenesis of lymphocytic choriomeningitis virus infection. (2002) (191)
Among CXCR3 Chemokines, IFN-γ-Inducible Protein of 10 kDa (CXC Chemokine Ligand (CXCL) 10) but Not Monokine Induced by IFN-γ (CXCL9) Imprints a Pattern for the Subsequent Development of Autoimmune Disease 1 (2003) (190)
Virus-induced alterations in homeostasis: alteration in differentiated functions of infected cells in vivo. (1982) (188)
A "string-of-beads" vaccine, comprising linked minigenes, confers protection from lethal-dose virus challenge (1993) (187)
Coexpression of B7-1 and viral ("self") transgenes in pancreatic beta cells can break peripheral ignorance and lead to spontaneous autoimmune diabetes. (1995) (185)
HIV and HCMV coinfect brain cells in patients with AIDS. (1988) (183)
Evidence for an Underlying CD4 Helper and CD8 T-Cell Defect in B-Cell-Deficient Mice: Failure To Clear Persistent Virus Infection after Adoptive Immunotherapy with Virus-Specific Memory Cells from μMT/μMT Mice (1998) (183)
Viral targeting of hematopoietic progenitors and inhibition of DC maturation as a dual strategy for immune subversion. (2004) (182)
Monoclonal antibodies to lymphocytic choriomeningitis and pichinde viruses: generation, characterization, and cross-reactivity with other arenaviruses. (1981) (181)
Entry versus Blockade of Brain Infection following Oral or Intraperitoneal Scrapie Administration: Role of Prion Protein Expression in Peripheral Nerves and Spleen (2000) (180)
Sphingosine-1-phosphate and its receptors: structure, signaling, and influence. (2013) (179)
Mapping the innate signaling cascade essential for cytokine storm during influenza virus infection (2014) (179)
Lymphocytic Choriomeningitis: Production of Antibody by "Tolerant" Infected Mice (1967) (177)
Synthetic peptide immunoassay distinguishes HIV type 1 and HIV type 2 infections. (1987) (176)
Mice devoid of prion protein have cognitive deficits that are rescued by reconstitution of PrP in neurons (2005) (172)
RNA editing enzyme adenosine deaminase is a restriction factor for controlling measles virus replication that also is required for embryogenesis (2010) (169)
V and C proteins of measles virus function as virulence factors in vivo. (2000) (169)
T suppressor (TG) lymphocytes fluctuate in parallel with changes in the clinical course of patients with multiple sclerosis. (1979) (169)
New World Arenavirus Clade C, but Not Clade A and B Viruses, Utilizes α-Dystroglycan as Its Major Receptor (2002) (168)
Evasion of Host Defenses by Measles Virus: Wild-Type Measles Virus Infection Interferes with Induction of Alpha/Beta Interferon Production (2000) (167)
Differences in Affinity of Binding of Lymphocytic Choriomeningitis Virus Strains to the Cellular Receptor α-Dystroglycan Correlate with Viral Tropism and Disease Kinetics (2001) (167)
Fine dissection of a nine amino acid glycoprotein epitope, a major determinant recognized by lymphocytic choriomeningitis virus-specific class I-restricted H-2Db cytotoxic T lymphocytes (1988) (166)
Multiple isoforms of CD46 (membrane cofactor protein) serve as receptors for measles virus. (1994) (166)
Viral persistence (1989) (165)
Oral insulin treatment suppresses virus-induced antigen-specific destruction of beta cells and prevents autoimmune diabetes in transgenic mice. (1996) (165)
Neuron-specific expression of a hamster prion protein minigene in transgenic mice induces susceptibility to hamster scrapie agent (1995) (163)
Diagnosis of AIDS by using a 12-amino acid peptide representing an immunodominant epitope of the human immunodeficiency virus. (1987) (162)
Replication and persistence of measles virus in defined subpopulations of human leukocytes (1975) (161)
Astrocytes are the primary source of tissue factor in the murine central nervous system. A role for astrocytes in cerebral hemostasis. (1993) (158)
Molecular analysis of the interaction of LCMV with its cellular receptor α-dystroglycan (2001) (157)
IL-10 blockade facilitates DNA vaccine-induced T cell responses and enhances clearance of persistent virus infection (2008) (156)
MicroRNAs of the miR-17~92 family are critical regulators of TFH differentiation (2013) (156)
Molecular Mimicry, Microbial Infection, and Autoimmune Disease: Evolution of the Concept (2005) (156)
Viruses perturb lymphocyte functions: selected principles characterizing virus-induced immunosuppression. (1987) (153)
Analyses of the cytotoxic T lymphocyte responses to glycoprotein and nucleoprotein components of lymphocytic choriomeningitis virus. (1988) (153)
Temperature-sensitive mutants of mouse hepatitis virus produce a high incidence of demyelination. (1978) (153)
Viral Infection of Transgenic Mice Expressing a Viral Protein in Oligodendrocytes Leads to Chronic Central Nervous System Autoimmune Disease (1996) (149)
Activation of cerebral cytokine gene expression and its correlation with onset of reactive astrocyte and acute-phase response gene expression in scrapie (1994) (148)
PATHOGENESIS OF CHRONIC DISEASE ASSOCIATED WITH PERSISTENT LYMPHOCYTIC CHORIOMENINGITIS VIRAL INFECTION (1969) (148)
Antiviral antibody reacting on the plasma membrane alters measles virus expression inside the cell (1979) (147)
IL-10 directly suppresses CD4 but not CD8 T cell effector and memory responses following acute viral infection (2010) (146)
Measles Virus Infection in a Transgenic Model Virus-Induced Immunosuppression and Central Nervous System Disease (1999) (145)
Active thymus derived suppressor lymphocytes in human cord blood (1977) (142)
Localization of Cytomegalovirus Proteins and Genome During Fulminant Central Nervous System Infection in an AIDS Patient (1986) (142)
A transgenic mouse model for measles virus infection of the brain. (1997) (142)
Molecular analyses of a five-amino-acid cytotoxic T-lymphocyte (CTL) epitope: an immunodominant region which induces nonreciprocal CTL cross-reactivity (1989) (142)
Induction and kinetics of natural killer cells in humans following interferon therapy (1979) (142)
An Essential Role for Type 1 Interferon-γ in Terminating Persistent Viral Infection (1995) (141)
Mechanisms for lymphocytic choriomeningitis virus glycoprotein cleavage, transport, and incorporation into virions. (2003) (140)
Posttranslational Modification of α-Dystroglycan, the Cellular Receptor for Arenaviruses, by the Glycosyltransferase LARGE Is Critical for Virus Binding (2005) (140)
Blockade of interferon Beta, but not interferon alpha, signaling controls persistent viral infection. (2015) (139)
Mechanism of lymphocytic choriomeningitis virus entry into cells. (1994) (139)
CD40 Ligand-Mediated Interactions Are Involved in the Generation of Memory CD8+ Cytotoxic T Lymphocytes (CTL) but Are Not Required for the Maintenance of CTL Memory following Virus Infection (1998) (138)
Molecular anatomy of viral persistence (1991) (138)
Immunologic injury in measles virus infection. II. Suppression of immune injury through antigenic modulation (1975) (137)
Vaccination and protection from a lethal viral infection: identification, incorporation, and use of a cytotoxic T lymphocyte glycoprotein epitope. (1990) (135)
Mouse hepatitis virus type 4 (JHM strains). induced fatal central nervous system disease. I. genetic control and murine neuron as the susceptible site of disease (1981) (135)
Clinical Isolates of Measles Virus Use CD46 as a Cellular Receptor (2000) (135)
Optimal lymphocytic choriomeningitis virus sequences restricted by H-2Db major histocompatibility complex class I molecules and presented to cytotoxic T lymphocytes (1995) (135)
Basal lamina strengthens cell membrane integrity via the laminin G domain-binding motif of α-dystroglycan (2009) (134)
THE EFFECT OF INDUCED CHRONIC VIRAL INFECTIONS ON THE IMMUNOLOGIC DISEASES OF NEW ZEALAND MICE (1970) (134)
Reprogramming of antiviral T cells prevents inactivation and restores T cell activity during persistent viral infection. (2006) (131)
Measles virus and C3 binding sites are distinct on membrane cofactor protein (CD46). (1995) (129)
Pathogenesis of murine cytomegalovirus infection: the macrophage as a permissive cell for cytomegalovirus infection, replication and latency. (1979) (129)
Molecularly engineered vaccine which expresses an immunodominant T-cell epitope induces cytotoxic T lymphocytes that confer protection from lethal virus infection (1989) (128)
Systemic alpha‐interferon therapy of multiple sclerosis (1984) (127)
Characterization of lymphocytic choriomeningitis virus-binding protein(s): a candidate cellular receptor for the virus (1992) (127)
Molecular definition of a major cytotoxic T-lymphocyte epitope in the glycoprotein of lymphocytic choriomeningitis virus (1988) (127)
Cytoimmunotherapy for persistent virus infection reveals a unique clearance pattern from the central nervous system. (1986) (127)
The primary structure of the lymphocytic choriomeningitis virus L gene encodes a putative RNA polymerase. (1989) (127)
Rapid activation of astrocyte-specific expression of GFAP-lacZ transgene by focal injury. (1991) (126)
Viruses disrupt functions of human lymphocytes. Effects of measles virus and influenza virus on lymphocyte-mediated killing and antibody production (1984) (126)
Surface markers on human B‐ and T‐lymphocytes. IX. Two‐color immunofluorescence studies on the association between EBV receptors and complement receptors on the surface of lymphoid cell lines (1976) (126)
Cure of prediabetic mice by viral infections involves lymphocyte recruitment along an IP-10 gradient. (2004) (125)
Pancreatic islet production of murine interleukin-10 does not inhibit immune-mediated tissue destruction. (1994) (124)
Molecular mimicry as a mechanism for the cause and a probe uncovering etiologic agent(s) of autoimmune disease. (1989) (124)
Consequences of cytotoxic T lymphocyte interaction with major histocompatibility complex class I-expressing neurons in vivo (1995) (124)
Molecular anatomy of antigen-specific CD8+ T cell engagement and synapse formation in vivo (2002) (123)
The antibody response of mice to murine leukemia virus in spontaneous infection: absence of classical immunologic tolerance (AKR mice-complement-fixing antibodies-lymphocytic choriomeningitis virus-immunofluorescence-glomerular deposits of antigen-antibody complexes). (1972) (123)
Persistent virus infection inhibits type I interferon production by plasmacytoid dendritic cells to facilitate opportunistic infections. (2008) (123)
Virus-lymphocyte interactions. IV. Molecular characterization of LCMV Armstrong (CTL+) small genomic segment and that of its variant, Clone 13 (CTL-). (1988) (121)
Virus-induced autoimmune disease (1996) (120)
Suppression of natural killer cell activity and T cell proliferation by fresh isolates of human cytomegalovirus. (1986) (120)
Alterations of acetylcholine enzymes in neuroblastoma cells persistently infected with lymphocytic choriomeningitis virus (1977) (120)
A critical role for the sphingosine analog AAL-R in dampening the cytokine response during influenza virus infection (2009) (118)
T cell recognition of HIV synthetic peptides in a natural infection. (1989) (117)
Restricted expression of viral glycoprotein in cells of persistently infected mice (1982) (116)
A viral epitope that mimics a self antigen can accelerate but not initiate autoimmune diabetes. (2004) (114)
Susceptible MHC alleles, not background genes, select an autoimmune T cell reactivity. (2003) (113)
Antibody-Mediated Destruction of Virus-Infected Cells (1980) (112)
Molecular characterization of the genomic S RNA segment from lymphocytic choriomeningitis virus. (1987) (112)
Interferon acts directly on human B lymphocytes to modulate immunoglobulin synthesis. (1981) (112)
Immunohistochemical study of allergic encephalomyelitis. (1968) (111)
HISTOCOMPATIBILITY-LINKED GENETIC CONTROL OF DISEASE SUSCEPTIBILITY: MURINE LYMPHOCYTIC CHORIOMENINGITIS VIRUS INJECTION (1973) (110)
The CD40-CD154 system in anti-infective host defense. (1997) (109)
Virus persistence and recurring demyelination produced by a temperature-sensitive mutant of MHV-4 (1982) (109)
Islet-Specific Expression of CXCL10 Causes Spontaneous Islet Infiltration and Accelerates Diabetes Development1 (2005) (108)
Virus-induced immunosuppression: infections with measles virus and human immunodeficiency virus. (1989) (107)
Protein structure of lymphocytic choriomeningitis virus: evidence for a cell-associated precursor of the virion glycopeptides. (1979) (107)
Neuronal cells are deficient in loading peptides onto MHC class I molecules (1992) (106)
Cerebral expression of multiple cytokine genes in mice with lymphocytic choriomeningitis. (1994) (105)
Long-term persistent vesicular stomatitis virus and rabies virus infection of cells in vitro. (1976) (105)
Virus persists in beta cells of islets of Langerhans and is associated with chemical manifestations of diabetes. (1984) (105)
An HLA-C-restricted CD8+ cytotoxic T-lymphocyte clone recognizes a highly conserved epitope on human immunodeficiency virus type 1 gag (1991) (104)
Like-acetylglucosaminyltransferase (LARGE)-dependent modification of dystroglycan at Thr-317/319 is required for laminin binding and arenavirus infection (2011) (103)
Viral persistence: parameters, mechanisms and future predictions. (2006) (103)
Point mutation in the glycoprotein of lymphocytic choriomeningitis virus is necessary for receptor binding, dendritic cell infection, and long-term persistence (2011) (101)
Selective localization of wild type and mutant mouse hepatitis virus (JHM strain) antigens in CNS tissue by fluorescence, light and electron microscopy (1981) (101)
Alpha and Beta Type 1 Interferon Signaling: Passage for Diverse Biologic Outcomes (2016) (100)
Inflammatory cells in transplanted kidneys are infected by human cytomegalovirus. (1988) (99)
PATHOGENESIS OF IMMUNE COMPLEX GLOMERULONEPHRITIS OF NEW ZEALAND MICE (1971) (98)
Characterization of the Interaction of Lassa Fever Virus with Its Cellular Receptor α-Dystroglycan (2005) (98)
Antibody-induced redistribution of measles virus antigens on the cell surface. (1974) (98)
Thymic selection and adaptability of cytotoxic T lymphocyte responses in transgenic mice expressing a viral protein in the thymus (1994) (97)
Cell Cycle Arrest during Measles Virus Infection: a G0-Like Block Leads to Suppression of Retinoblastoma Protein Expression (1999) (97)
Medical consequences of persistent viral infection. (1986) (97)
Unique Small Molecule Entry Inhibitors of Hemorrhagic Fever Arenaviruses* (2008) (96)
Immunologic injury of cultured cells infected with measles virus. I. role of IfG antibody and the alternative complement pathway (1975) (96)
Myelin-Associated Oligodendrocytic Basic Protein: Identification of an Encephalitogenic Epitope and Association with Multiple Sclerosis1 (2000) (96)
Viruses as therapeutic agents. I. Treatment of nonobese insulin- dependent diabetes mice with virus prevents insulin-dependent diabetes mellitus while maintaining general immune competence (1990) (95)
c-Jun NH2-Terminal Kinase (JNK)1 and JNK2 Signaling Pathways Have Divergent Roles in CD8+ T Cell–mediated Antiviral Immunity (2002) (95)
The signal sequence of lymphocytic choriomeningitis virus contains an immunodominant cytotoxic T cell epitope that is restricted by both H-2D(b) and H-2K(b) molecules. (1997) (94)
In vivo expression of perforin by CD8+ lymphocytes during an acute viral infection [published erratum appears in J Exp Med 1989 Dec 1;170(6):2191] (1989) (94)
Mechanism of injury of virus-infected cells by antiviral antibody and complement: participation of IgG, F(ab')2, and the alternative complement pathway (1976) (94)
Measles virus inhibits mitogen-induced T cell proliferation but does not directly perturb the T cell activation process inside the cell. (1992) (94)
Measles virus-mononuclear cell interactions. (1995) (93)
Lymphocytes from human newborns abrogate mitosis of their mother's lymphocytes (1974) (93)
Inactivation of lysis of oncornaviruses by human serum. (1976) (92)
IMMUNE COMPLEX DISEASE IN CHRONIC VIRAL INFECTIONS (1971) (91)
Virus-induced immunosuppression. 1. Age at infection relates to a selective or generalized defect. (1993) (90)
Site-specific antibodies define a cleavage site conserved among arenavirus GP-C glycoproteins (1987) (90)
How viruses escape from cytotoxic T lymphocytes: molecular parameters and players. (1997) (89)
Protein structure of lymphocytic choriomeningitis virus: identification of the virus structural and cell associated polypeptides. (1978) (88)
Islet inflammation and hyperplasia induced by the pancreatic islet-specific overexpression of interleukin-6 in transgenic mice. (1994) (88)
Evidence that the hypermutated M protein of a subacute sclerosing panencephalitis measles virus actively contributes to the chronic progressive CNS disease. (2001) (87)
Genetic mapping of lymphocytic choriomeningitis virus pathogenicity: virulence in guinea pigs is associated with the L RNA segment (1985) (87)
Antibody-independent activation of the alternative complement pathway by measles virus-infected cells. (1980) (86)
Antibody-complement interactions with purified lymphocytic choriomeningitis virus. (1976) (86)
IL-10 induces aberrant deletion of dendritic cells by natural killer cells in the context of HIV infection. (2010) (86)
Suppression of T lymphocyte function by measles virus is due to cell cycle arrest in G1. (1988) (84)
CTL escape viral variants. I. Generation and molecular characterization. (1995) (84)
Immunologic injury in measles virus infection. III. Presence and characterization of human cytotoxic lymphocytes. (1977) (83)
Immunologic regulation of fetal-maternal balance. (1984) (83)
Resistance to Chronic Wasting Disease in Transgenic Mice Expressing a Naturally Occurring Allelic Variant of Deer Prion Protein (2007) (83)
Host Immunoglobulin G and Complement Deposits in the Choroid Plexus during Spontaneous Immune Complex Disease (1973) (82)
Vaccination to prevent persistent viral infection (1993) (81)
Detailed in vivo analysis of interferon-gamma induced major histocompatibility complex expression in the the central nervous system: astrocytes fail to express major histocompatibility complex class I and II molecules. (1999) (81)
The S RNA segment of lymphocytic choriomeningitis virus codes for the nucleoprotein and glycoproteins 1 and 2 (1985) (79)
Measles virus interacts with human SLAM receptor on dendritic cells to cause immunosuppression. (2004) (79)
An essential role for type 1 interferon-gamma in terminating persistent viral infection. (1995) (78)
Interferon production during lymphocytic choriomeningitis virus infection of nude and normal mice (1977) (78)
Measles virus infection of B lymphocytes permits cellular activation but blocks progression through the cell cycle (1987) (78)
Does the major histocompatibility complex serve as a specific receptor for Semliki Forest virus? (1980) (77)
Interactions between viruses and lymphocytes. I. In vivo replication of lymphocytic choriomeningitis virus in mononuclear cells during both chronic and acute viral infections. (1978) (77)
Networking at the level of host immunity: immune cell interactions during persistent viral infections. (2013) (77)
Cell cycle-dependent immune lysis of Moloney virus-transformed lymphocytes: presence of viral antigen, accessibility to antibody, and complement activation. (1971) (77)
Infection of lymphocytes by a virus that aborts cytotoxic T lymphocyte activity and establishes persistent infection (1991) (77)
Expression of adenoviral E3 transgenes in beta cells prevents autoimmune diabetes. (1997) (77)
Organ-specific selection of viral variants during chronic infection [published erratum appears in J Exp Med 1988 Jul 1;168(1):457] (1988) (76)
Inhibition of Antibodies to Nuclear Antigen and to DNA in New Zealand Mice Infected with Lactate Dehydrogenase Virus (1972) (76)
Cytokine Storm Plays a Direct Role in the Morbidity and Mortality from Influenza Virus Infection and is Chemically Treatable with a Single Sphingosine-1-Phosphate Agonist Molecule (2014) (76)
B- and T-lymphocyte responses to an immunodominant epitope of human immunodeficiency virus (1988) (76)
Measles virus recognizes its receptor, CD46, via two distinct binding domains within SCR1-2. (1997) (75)
Pathogenesis of the slow disease of the central nervous system associated with WM 1504 E virus. I. Relationship of strain susceptibility and replication to disease. (1977) (75)
Analysis of persistent virus infections by in situ hybridization to whole-mouse sections (1984) (74)
Inhibition of mitosis of lymphocytes from human adults by lymphocytes from human newborns. (1974) (74)
Measles Virus Infects and Suppresses Proliferation of T Lymphocytes from Transgenic Mice Bearing Human Signaling Lymphocytic Activation Molecule (2003) (73)
Cytotoxic T lymphocyte control of acute lymphocytic choriomeningitis virus infection: interferon gamma, but not tumour necrosis factor alpha, displays antiviral activity in vivo. (1989) (72)
Toll-like receptor 7 is required for effective adaptive immune responses that prevent persistent virus infection. (2012) (72)
Cells that express viral antigens but lack H-2 determinants are not lysed by immune thymus-derived lymphocytes but are lysed by other antiviral immune attack mechanisms. (1976) (71)
Decoding arenavirus pathogenesis: essential roles for alpha-dystroglycan-virus interactions and the immune response. (2011) (71)
T Cells Infiltrate the Brain in Murine and Human Transmissible Spongiform Encephalopathies (2003) (71)
Lymphotoxin-β-deficient mice show defective antiviral immunity (1999) (70)
Studies using double mutants of the conformational transitions in influenza hemagglutinin required for its membrane fusion activity. (1996) (70)
Virus-lymphocyte interaction: T cells of the helper subset are infected with lymphocytic choriomeningitis virus during persistent infection in vivo (1987) (70)
Local Not Systemic Modulation of Dendritic Cell S1P Receptors in Lung Blunts Virus-Specific Immune Responses to Influenza (2008) (69)
Recent clinical isolates of cytomegalovirus suppress human cytomegalovirus-specific human leukocyte antigen-restricted cytotoxic T-lymphocyte activity (1986) (69)
CTL escape viral variants. II. Biologic activity in vivo. (1995) (68)
Virus-induced immune complex disease: identification of specific viral antigens and antibodies deposited in complexes during chronic lymphocytic choriomeningitis virus infection. (1978) (68)
Reversal of virus-induced systemic shock and respiratory failure by blockade of the lymphotoxin pathway (1999) (67)
Ultrastructural localization of viral antigens in the CNS of mice persistently infected with lymphocytic choriomeningitis virus (LCMV). (1983) (66)
Lysis of measles virus-infected cells by the purified cytolytic alternative complement pathway and antibody (1979) (66)
Binding of Viral Antigens to Major Histocompatibility Complex Class I H-2Db Molecules Is Controlled by Dominant Negative Elements at Peptide Non-anchor Residues (1996) (66)
Measles virus-dendritic cell interaction via SLAM inhibits innate immunity: selective signaling through TLR4 but not other TLRs mediates suppression of IL-12 synthesis. (2007) (66)
Simian immunodeficiency virus (SIV)-specific CTL in cerebrospinal fluid and brains of SIV-infected rhesus macaques. (1995) (65)
Defining parameters for successful immunocytotherapy of persistent viral infection. (2000) (65)
Class I MHC can present an endogenous peptide to cytotoxic T lymphocytes (1989) (64)
EVIDENCE FOR IMMUNE-COMPLEX FORMATION IN PATIENTS WITH AMYOTROPHIC LATERAL SCLEROSIS (1976) (64)
Pathogenesis of cytomegalovirus infection. Distribution of viral products, immune complexes and autoimmunity during latent murine infection. (1976) (64)
Identification and expression of a human cytomegalovirus early glycoprotein (1989) (64)
Restricted V-segment usage in T-cell receptors from cytotoxic T lymphocytes specific for a major epitope of lymphocytic choriomeningitis virus (1990) (64)
Receptor structure, binding, and cell entry of arenaviruses. (2002) (63)
Broadband Modulation of Light by Using an Electro-Optic Polymer (2002) (63)
Decrease in measles virus-specific CD4 T cell memory in vaccinated subjects. (2004) (63)
Infection of dendritic cells by lymphocytic choriomeningitis virus. (2003) (63)
T cells in the central nervous system: the delicate balance between viral clearance and disease. (2002) (62)
Tissue injury in lymphocytic choriomeningitis viral infection: virus-induced immunologically specific release of a cytotoxic factor from immune lymphoid cells. (1970) (62)
Generalized immunosuppression: how viruses undermine the immune response (2000) (62)
Detection of Low-Avidity CD4+ T Cells Using Recombinant Artificial APC: Following the Antiovalbumin Immune Response1 (2003) (62)
Anatomy of viral persistence: mechanisms of persistence and associated disease. (1996) (62)
Perturbation of differentiated functions during viral infection in vivo. I. Relationship of lymphocytic choriomeningitis virus and host strains to growth hormone deficiency. (1985) (62)
Use of alternative receptors different than alpha-dystroglycan by selected isolates of lymphocytic choriomeningitis virus. (2004) (62)
Characterization of the inflammatory response during acute measles encephalitis in NSE-CD46 transgenic mice (1999) (62)
Adoptive immunotherapy induces CNS dendritic cell recruitment and antigen presentation during clearance of a persistent viral infection (2006) (61)
A common antiviral cytotoxic T-lymphocyte epitope for diverse major histocompatibility complex haplotypes: implications for vaccination. (1992) (60)
Lack of Intrinsic CTLA-4 Expression Has Minimal Effect on Regulation of Antiviral T-Cell Immunity (2006) (60)
In vitro generation of human cytotoxic lymphocytes by virus. Viral glycoproteins induce nonspecific cell-mediated cytotoxicity without release of interferon (1981) (60)
Virus specificity of cytotoxic T lymphocytes generated during acute lymphocytic choriomeningitis virus infection: role of the H-2 region in determining cross-reactivity for different lymphocytic choriomeningitis virus strains (1984) (59)
A single amino acid change in the glycoprotein of lymphocytic choriomeningitis virus is associated with the ability to cause growth hormone deficiency syndrome (1996) (59)
Selective disruption of growth hormone transcription machinery by viral infection. (1992) (59)
Disease activity markers in multiple sclerosis Another look at suppressor cells defined by monoclonal antibodies OKT4, OKT5, and OKT8 (1984) (59)
Role of viruses in type I diabetes. (1998) (59)
T-cell receptors from virus-specific cytotoxic T lymphocytes recognizing a single immunodominant nine-amino-acid viral epitope show marked diversity (1994) (58)
Alternative complement pathway-mediated lysis of measles virus infected cells: induction by IgG antibody bound to individual viral glycoproteins and comparative efficacy of F(ab')2 and Fab' fragments. (1979) (58)
Viral infection of neurons can depress neurotransmitter mRNA levels without histologic injury (1988) (58)
Measles virus infection results in suppression of both innate and adaptive immune responses to secondary bacterial infection. (2003) (58)
A CD4+ cytotoxic T-lymphocyte clone to a conserved epitope on human immunodeficiency virus type 1 p24: cytotoxic activity and secretion of interleukin-2 and interleukin-6 (1992) (57)
Crystal structure of the prefusion surface glycoprotein of the prototypic arenavirus LCMV (2016) (57)
Biology of cloned cytotoxic T lymphocytes specific for lymphocytic choriomeningitis virus. I. Generation and recognition of virus strains and H-2b mutants. (1984) (57)
Diversity of T-cell receptors in virus-specific cytotoxic T lymphocytes recognizing three distinct viral epitopes restricted by a single major histocompatibility complex molecule (1992) (57)
Infected CD8α− dendritic cells are the predominant source of IL-10 during establishment of persistent viral infection (2012) (57)
Mapping the anatomy of the immunodominant domain of the human immunodeficiency virus gp41 transmembrane protein: peptide conformation analysis using monoclonal antibodies and proton nuclear magnetic resonance spectroscopy (1991) (56)
Dissecting influenza virus pathogenesis uncovers a novel chemical approach to combat the infection. (2013) (56)
Competitive selection in vivo by a cell for one variant over another: implications for RNA virus quasispecies in vivo (1996) (56)
Viral alteration of cell function. (1989) (55)
FORMATION AND BIOLOGIC ROLE OF POLYOMA VIRUS-ANTIBODY COMPLEXES (1974) (55)
Prion-Induced Amyloid Heart Disease with High Blood Infectivity in Transgenic Mice (2006) (55)
Type I interferon is a therapeutic target for virus-induced lethal vascular damage (2014) (55)
Lymphotoxin-α- and Lymphotoxin-β-Deficient Mice Differ in Susceptibility to Scrapie: Evidence against Dendritic Cell Involvement in Neuroinvasion (2002) (54)
Is herpes simplex virus associated with peptic ulcer disease? (1990) (54)
Animal Model of Respiratory Syncytial Virus: CD8+ T Cells Cause a Cytokine Storm That Is Chemically Tractable by Sphingosine-1-Phosphate 1 Receptor Agonist Therapy (2014) (54)
Suppression of lymphocytic choriomeningitis virus--induced growth hormone deficiency syndrome by disease-negative virus variants. (1996) (53)
Quelling the storm: utilization of sphingosine-1-phosphate receptor signaling to ameliorate influenza virus-induced cytokine storm (2011) (53)
Focal expression of interleukin-2 does not break unresponsiveness to "self" (viral) antigen expressed in beta cells but enhances development of autoimmune disease (diabetes) after initiation of an anti-self immune response. (1995) (53)
Delineation of suppressor and helper activity within the OKT4-defined T lymphocyte subset in human newborns. (1983) (53)
Sensitization to self (virus) antigen by in situ expression of murine interferon-gamma. (1995) (53)
Discriminated selection among viral peptides with the appropriate anchor residues: implications for the size of the cytotoxic T-lymphocyte repertoire and control of viral infection (1995) (53)
Viral persistence in neurons alters synaptic plasticity and cognitive functions without destruction of brain cells. (1996) (53)
Virus-Induced Diabetes in a Transgenic Model: Role of Cross-Reacting Viruses and Quantitation of Effector T Cells Needed To Cause Disease (2000) (53)
Viruses can cause disease in the absence of morphological evidence of cell injury: implication for uncovering new diseases in the future. (1989) (53)
Cytotoxic T lymphocytes cleanse viral gene products from individually infected neurons and lymphocytes in mice persistently infected with lymphocytic choriomeningitis virus. (1993) (52)
Pathogenesis of the slow disease of the central nervous system associated with wild mouse virus. II. Role of virus and host gene products. (1980) (52)
Persistent lymphocytic choriomeningitis viral infection. 3. Virus-anti-viral antibody complexes and associated chronic disease following transplacental infection. (1970) (52)
Detection of cytomegalovirus nucleic acid sequences in pancreas in type 2 diabetes (1990) (52)
Analysis of CD8+ T cell response during the 2013–2016 Ebola epidemic in West Africa (2018) (52)
Old World arenavirus infection interferes with the expression of functional alpha-dystroglycan in the host cell. (2007) (51)
Type I interferon during viral infections: multiple triggers for a multifunctional mediator. (2007) (51)
Vaccination to treat persistent viral infection (2000) (50)
Mass spectrometry reveals specific and global molecular transformations during viral infection. (2006) (50)
Immune complex disease associated with spontaneous murine leukemia: Incidence and pathogenesis of glomerulonephritis☆ (1972) (50)
Interferon-g Is Essential for Destruction of b Cells and Development of Insulin-dependent Diabetes Mellitus (1997) (50)
Virus and immune responses: lymphocytic choriomeningitis virus as a prototype model of viral pathogenesis. (1985) (50)
Virus-lymphocyte interactions. III. Biologic parameters of a virus variant that fails to generate CTL and establishes persistent infection in immunocompetent hosts. (1988) (49)
Low-Affinity Cytotoxic T-Lymphocytes Require IFN-γ to Clear an Acute Viral Infection ☆ (1997) (49)
Acute viral infection: tissue injury mediated by anti-viral antibody through a complement effector system. (1971) (49)
Organ- and age-specific replication of polyomavirus in mice (1992) (48)
Selected mutants of mouse hepatitis virus type 4 (JHM strain) induce different CNS diseases. Pathobiology of disease induced by wild type and mutants ts8 and ts15 in BALB/c and SJL/J mice. (1982) (48)
Common immunologic determinant between human immunodeficiency virus type 1 gp41 and astrocytes (1991) (48)
Malaria: Drugs, Disease and Post-genomic Biology (2005) (47)
Viruses as therapeutic agents. II. Viral reassortants map prevention of insulin-dependent diabetes mellitus to the small RNA of lymphocytic choriomeningitis virus (1990) (47)
Virus-induced immunosuppression: kinetic analysis of the selection of a mutation associated with viral persistence (1994) (47)
Design of high-affinity major histocompatibility complex-specific antagonist peptides that inhibit cytotoxic T-lymphocyte activity: implications for control of viral disease (1992) (47)
Anatomy of Viral Persistence (2009) (47)
Using Transgenic Mouse Models to Dissect the Pathogenesis of Virus‐Induced Autoimmune Disorders of the Islets of Langerhans and the Central Nervous System (1996) (46)
Effect of chronic viral infection on the immune system. I. Comparison of the immune responsiveness of mice chronically infected with LCM virus with that of noninfected mice. (1973) (46)
Genetic reassortants of lymphocytic choriomeningitis virus: unexpected disease and mechanism of pathogenesis (1986) (46)
Disruption of MyD88 signaling suppresses hemophagocytic lymphohistiocytosis in mice. (2011) (45)
Prevention of virus-induced cerebellar diseases by defective-interfering lymphocytic choriomeningitis virus. (1977) (45)
In vivo treatment with a MHC class I-restricted blocking peptide can prevent virus-induced autoimmune diabetes. (1998) (45)
Preferential Escape of Subdominant CD8+ T Cells During Negative Selection Results in an Altered Antiviral T Cell Hierarchy 1 (2003) (44)
Visualizing the Viral Burden: Phenotypic and Functional Alterations of T Cells and APCs during Persistent Infection 1 (2004) (43)
Progression of type 1 diabetes from the prediabetic stage is controlled by interferon-α signaling (2017) (43)
Structural and functional studies of the measles virus hemagglutinin: identification of a novel site required for CD46 interaction. (1999) (43)
CD4 T cell control primary measles virus infection of the CNS: regulation is dependent on combined activity with either CD8 T cells or with B cells: CD4, CD8 or B cells alone are ineffective. (2006) (43)
The expression of major histocompatibility complex (MHC) class I antigens in the brain differs markedly in acute and persistent infections with lymphocytic choriomeningitis virus (LCMV) (1992) (43)
Virus-lymphocyte interactions: infection of Tg and Tm subsets by measles virus. (1980) (42)
Virus-lymphocyte interactions. II. Expression of viral sequences during the course of persistent lymphocytic choriomeningitis virus infection and their localization to the L3T4 lymphocyte subset. (1988) (41)
S1PR1-mediated IFNAR1 degradation modulates plasmacytoid dendritic cell interferon-α autoamplification (2016) (41)
Murine cytomegalovirus infects spermatogenic cells. (1979) (41)
Viral persistence and disease: cytopathology in the absence of cytolysis. (1991) (41)
Virus Can Alter Cell Function Without Causing Cell Pathology: Disordered Function Leads to Imbalance of Homeostasis and Disease (1984) (41)
Autoimmune diabetes can be induced in transgenic major histocompatibility complex class II-deficient mice (1993) (41)
Lysis of oncornaviruses by human serum. (1975) (40)
Perturbation of differentiated functions during viral infection in vivo. II. Viral reassortants map growth hormone defect to the S RNA of the lymphocytic choriomeningitis virus genome. (1985) (40)
Susceptibility of different mouse strains to lymphocytic choriomeningitis virus. (1968) (39)
Human histocompatibility determinants and virus antigens: effect of measles virus infection on HLA expression (1977) (39)
Lactic dehydrogenase virus-induced immune complex type of glomerulonephritis. (1971) (38)
Membrane and cytoplasmic changes in virus-infected cells induced by interactions of antiviral antibody with surface viral antigen. (1980) (38)
Neurotransmitter abnormalities in Borna disease (1988) (38)
Slc15a4, a Gene Required for pDC Sensing of TLR Ligands, Is Required to Control Persistent Viral Infection (2012) (37)
Mapping and restriction of a dominant viral CD4+ T cell core epitope by both MHC class I and MHC class II. (2007) (37)
A RE-EVALUATION OF BLOOD CULTURE AS AN AUTOPSY PROCEDURE. (1965) (37)
Constitutive beta cell expression of IL-12 does not perturb self-tolerance but intensifies established autoimmune diabetes. (2001) (37)
Virus-lymphoid cell interactions. (1996) (37)
Viral persistence: mechanisms and consequences. (1998) (37)
A role for dual viral hits in causation of subacute sclerosing panencephalitis (2005) (36)
Efficiency and effectiveness of cloned virus-specific cytotoxic T lymphocytes in vivo. (1989) (36)
Killing of virus-infected cells by cytotoxic lymphocytes. (1980) (36)
Three Phases of CD8 T Cell Response in the Lung Following H1N1 Influenza Infection and Sphingosine 1 Phosphate Agonist Therapy (2013) (36)
A new approach for evaluating antigen-specific T cell responses to myelin antigens during the course of multiple sclerosis (2003) (36)
Mechanisms and Biological Implications of Virus-Induced Polyclonal B-Cell Activation (1984) (36)
HISTOCOMPATIBILITY-LINKED GENETIC CONTROL OF DISEASE SUSCEPTIBILITY (1973) (36)
A suspenseful game of 'hide and seek' between virus and host (2007) (35)
Immortalized clones of fibroblastic reticular cells activate virus-specific T cells during virus infection (2012) (34)
Natural killer cells activity in patients with multiple sclerosis given α interferon (1983) (34)
IL-10: achieving balance during persistent viral infection. (2014) (34)
The role of cytotoxic T lymphocytes in infectious disease: history, criteria, and state of the art. (1994) (34)
Histocompatibility‐Linked Genetic Control of Specific Immune Responses to Viral Infection (1974) (33)
Lymphotoxin-alpha- and lymphotoxin-beta-deficient mice differ in susceptibility to scrapie: evidence against dendritic cell involvement in neuroinvasion. (2002) (33)
PATHOGENIC MECHANISMS OF TISSUE INJURY IN PERSISTENT VIRAL INFECTIONS * (1975) (33)
Detection of Prion Infectivity in Fat Tissues of Scrapie-Infected Mice (2008) (33)
Pathogenesis of the slow disease of the central nervous system associated with wild mouse virus. III. Role of input virus and MCF recombinants in disease. (1983) (33)
CD2-deficient mice generate virus-specific cytotoxic T lymphocytes upon infection with lymphocytic choriomeningitis virus. (1993) (33)
Failure to detect genomic viral sequences in pancreatic tissues from two children with acute‐onset diabetes mellitus (1994) (33)
Protection of ferrets from pulmonary injury due to H1N1 2009 influenza virus infection: immunopathology tractable by sphingosine-1-phosphate 1 receptor agonist therapy. (2014) (32)
Lessons learned and concepts formed from study of the pathogenesis of the two negative-strand viruses lymphocytic choriomeningitis and influenza (2013) (32)
Behavioral effects of persistent lymphocytic choriomeningitis virus infection in mice. (1994) (32)
Arenaviruses. I. The epidemiology molecular and cell biology of arenaviruses. Introduction. (2002) (32)
CD8 T cell defect of TNF-α and IL-2 in DNAM-1 deficient mice delays clearance in vivo of a persistent virus infection. (2012) (31)
Influenza Pathogenesis and Control - Volume I (2014) (31)
Immunotherapy for virus infection. (1987) (31)
Virus-Induced Immune Complex Formation and Disease: Definition, Regulation, Importance (1984) (31)
An Outbreak of Ebola Virus Disease in the Lassa Fever Zone. (2016) (31)
Lymphotoxin-beta-deficient mice show defective antiviral immunity. (1999) (31)
Pituitary dwarfism in mice persistently infected with lymphocytic choriomeningitis virus. (1983) (31)
Biology of cloned cytotoxic T lymphocytes specific for lymphocytic choriomeningitis virus. VI. Migration and activity in vivo in acute and persistent infection. (1986) (30)
More mayhem from molecular mimics (1997) (30)
Chronic wasting disease of deer and elk in transgenic mice: oral transmission and pathobiology. (2007) (30)
Biology of cloned cytotoxic T lymphocytes specific for lymphocytic choriomeningitis virus. V. Recognition is restricted to gene products encoded by the viral S RNA segment. (1986) (30)
Early Virus-Host Interactions Dictate the Course of a Persistent Infection (2015) (30)
Neither B Lymphocytes Nor Antibodies Directed Against Self Antigens of the Islets of Langerhans Are Required for Development of Virus-Induced Autoimmune Diabetes1 2 (2000) (30)
Deficits in discriminated learning remain despite clearance of long-term persistent viral infection in mice. (1997) (29)
Propagation of RML Prions in Mice Expressing PrP Devoid of GPI Anchor Leads to Formation of a Novel, Stable Prion Strain (2012) (29)
Structural and Functional Identification of Major Histocompatibility Complex Class I-restricted Self-peptides as Naturally Occurring Molecular Mimics of Viral Antigens (2001) (29)
Targeting Schwann cells by nonlytic arenaviral infection selectively inhibits myelination (2003) (29)
Immune Responses, Immune Tolerance, and Viruses (1979) (29)
Disruption of copper homeostasis due to a mutation of Atp7a delays the onset of prion disease (2012) (29)
Subacute sclerosing panencephalitis: destruction of human brain cells by antibody and complement in an autologous system. (1975) (29)
Altered Central Nervous System Gene Expression Caused by Congenitally Acquired Persistent Infection with Lymphocytic Choriomeningitis Virus (2006) (29)
DISEASE ACCOMPANYING IN UTERO VIRAL INFECTION (1972) (28)
In vivo conversion of BM plasmacytoid DC into CD11b+ conventional DC during virus infection (2008) (28)
Detection of Naturally Occurring Antibodies to RNA-Dependent DNA Polymerase of Murine Leukemia Virus in Kidney Eluates of AKR Mice (1974) (28)
Treatment with a sphingosine analog does not alter the outcome of a persistent virus infection. (2010) (28)
Discovery of Small Molecules for the Reversal of T Cell Exhaustion. (2019) (28)
Biology of cloned cytotoxic T lymphocytes specific for lymphocytic choriomeningitis virus: clearance of virus and in vitro properties (1985) (28)
A model of measles virus–induced immunosuppression: Enhanced susceptibility of neonatal human PBLs (1996) (28)
Lymphocytic choriomeningitis virus Clone 13 infection causes either persistence or acute death dependent on IFN-1, cytotoxic T lymphocytes (CTLs), and host genetics (2018) (28)
A comparison of biochemical and biological properties of standard and defective lymphocytic choriomeningitis virus. (1975) (27)
Host genetic control of mouse hepatitis virus type 4 (JHM strain) replication. I. Restriction of virus amplification and spread in macrophages from resistant mice. (1984) (27)
Macrophage IFN-I signaling promotes autoreactive T cell infiltration into islets in type 1 diabetes model. (2019) (27)
The formation and fate of virus antigen-antibody complexes. (1977) (27)
Lymphocytic choriomeningitis virus selectively alters differentiated but not housekeeping functions: block in expression of growth hormone gene is at the level of transcriptional initiation. (1989) (27)
Purification of measles virus glycoproteins and their integration into artificial lipid membranes. (1981) (27)
Persistent viral infection of the thyroid gland: alteration of thyroid function in the absence of tissue injury. (1988) (26)
Overview: infectious agents as etiologic triggers of autoimmune disease. (1989) (26)
Molecular mimicry accompanying HIV-1 infection: human monoclonal antibodies that bind to gp41 and to astrocytes. (1993) (26)
Measurement of virus antigens on the surface of HeLa cells persistently infected with wild type and vaccine strains of measles virus by radioimmune assay. (1976) (26)
Immunologic injury in measles virus infection. IV. Antigens modulation and abrogation oflymphocyte lysis of virus-infected cells. (1978) (26)
Virus-induced immune complex disease: specific anti-viral antibody and C1q binding material in the circulation during persistent lymphocytic choriomeningitis virus infection. (1980) (26)
Modeling subacute sclerosing panencephalitis in a transgenic mouse system: uncoding pathogenesis of disease and illuminating components of immune control. (2009) (26)
Mechanisms of killing of measles virus-infected cells by human lymphocytes: interferon associated and unassociated cell-mediated cytotoxicity. (1982) (26)
Host genetic control of mouse hepatitis virus type-4 (JHM strain) replication. II. The gene locus for susceptibility is linked to the Svp-2 locus on mouse chromosome 7. (1984) (26)
Perturbation of differentiated functions in vivo during persistent viral infection. III. Decreased growth hormone mRNA. (1987) (25)
Molecular Anatomy and Number of Antigen Specific CD8 T Cells Required to Cause Type 1 Diabetes (2012) (25)
Trafficking of activated cytotoxic T lymphocytes into the central nervous system: Use of a transgenic model (1993) (25)
Autologous immune responses to the major oncornavirus polypeptides in unmanipulated AKR/J mice (1976) (25)
Antigen presentation and cytotoxic T lymphocyte killing studied in individual, living cells. (1994) (24)
Characterization of lassa virus cell entry inhibitors: determination of the active enantiomer by asymmetric synthesis. (2009) (24)
Immune complexes in viral infection. (1983) (24)
Hypomorphic mutation in the site-1 protease Mbtps1 endows resistance to persistent viral infection in a cell-specific manner. (2011) (24)
Variants able to cause growth hormone deficiency syndrome are present within the disease-nil WE strain of lymphocytic choriomeningitis virus (1996) (24)
Failure of terminal complement components to induce lysis of Moloney virus transformed lymphocytes. (1974) (24)
Virus and cytotoxic T lymphocytes: crucial role of viral peptide secondary structure in major histocompatibility complex class I interactions (1993) (24)
Molecular analysis of the interaction of LCMV with its cellular receptor (cid:2) -dystroglycan (2001) (24)
HIV versus cytotoxic T lymphocytes--the war being lost. (1997) (23)
Pathogenesis of Lassa fever virus infection: I. Susceptibility of mice to recombinant Lassa Gp/LCMV chimeric virus. (2013) (23)
Role of viruses in the loss of tolerance to self-antigens and in autoimmune diseases. (1995) (23)
Chronic virus infection and immune responsiveness. II. Lactic dehydrogenase virus infection and immune response to non-viral antigens. (1974) (23)
Suppressor T cells are activated in vivo in patients with multiple sclerosis coinciding with remission from acute attack. (1982) (23)
Disturbance of pituitary-adrenal interrelationships in benign intracranial hypertension (pseudotumor cerebri). (1966) (23)
Genetically Encoded and Post-translationally Modified Forms of a Major Histocompatibility Complex Class I-restricted Antigen Bearing a Glycosylation Motif Are Independently Processed and Co-presented to Cytotoxic T Lymphocytes* (1999) (23)
The pathogenesis of cellular injury associated with persistent lcm viral infection. Abstr. (1969) (23)
Virus persists in beta cells of islets of Langerhans and infection is associated with chemical manifestations of diabetes. II. Morphologic observations. (1985) (23)
Concepts in viral pathogenesis (1984) (22)
Virus-induced immune complex disease: genetic control of C1q binding complexes in the circulation of mice persistently infected with lymphocytic choriomeningitis virus. (1983) (22)
Use of a high-affinity peptide that aborts MHC-restricted cytotoxic T lymphocyte activity against multiple viruses in vitro and virus-induced immunopathologic disease in vivo. (1999) (22)
Pathogenesis and treatment of virus-induced autoimmune diabetes: novel insights gained from the RIP-LCMV transgenic mouse model. (1997) (22)
Expanded Potential for Recombinant Trisegmented Lymphocytic Choriomeningitis Viruses: Protein Production, Antibody Production, and In Vivo Assessment of Biological Function of Genes of Interest (2011) (22)
IMMUNE COMPLEX DISEASE ASSOCIATED WITH VIRAL INFECTIONS (1975) (22)
Molecular and cellular mechanisms, pathogenesis, and treatment of insulin-dependent diabetes obtained through study of a transgenic model of molecular mimicry. (2005) (22)
Activation of Spontaneous Murine Leukemia Virus-Related Antigen by Lymphocytic Choriomeningitis Virus (1971) (21)
One, two, or three step: measles virus receptor dance. (2002) (21)
Persistent virus infection associated with chemical manifestations of diabetes. II. Role of viral strain, environmental insult, and host genetics. (1987) (21)
Transgenic mice expressing human HLA and CD8 molecules generate HLA-restricted measles virus cytotoxic T lymphocytes of the same specificity as humans with natural measles virus infection. (2000) (20)
Low-affinity cytotoxic T-lymphocytes require IFN-gamma to clear an acute viral infection. (1997) (20)
Defining the Conformational Features of Anchorless, Poorly Neuroinvasive Prions (2013) (20)
Humoral immunity in guamanians with amyotrophic lateral sclerosis and parkinsonism‐dementia (1981) (20)
Relative implication of peptide residues in binding to major histocompatibility complex class I H-2Db: application to the design of high-affinity, allele-specific peptides. (1995) (20)
Mechanism and consequence of viral persistence in cells of the immune system and neurons. (1993) (20)
Antibody Initiates Virus Persistence: Immune Modulation and Measles Virus Infection (1984) (20)
High crossreactivity of human T cell responses between Lassa virus lineages (2020) (20)
Replication of murine cytomegalovirus in reproductive tissues. (1980) (19)
Principles of Viral Pathogenesis (1996) (19)
The role of dendritic cells in viral persistence. (2011) (18)
Common Antiviral Cytotoxic T-Lymphocyte Epitope for Diverse Arenaviruses (2001) (18)
Immune reactive measles virus polypeptides on the cell's surface: turnover and relationship of the glycoproteins to each other and to HLA determinants. (1981) (18)
α-Dystroglycan can mediate arenavirus infection in the absence of β-dystroglycan (2003) (18)
A new solid-phase enzyme-linked immunosorbent assay for specific antibodies to measles virus. (1983) (18)
Clinical Trial of Natural Alpha Interferon in Multiple Sclerosis a (1984) (18)
Rous-Whipple Award Lecture. Viruses and diseases of the twenty-first century. (1993) (18)
A selective defect in tissue factor mRNA expression in monocytes from AIDS patients. (1990) (17)
Transgenic Models of Human Viral and Immunological Disease (2013) (17)
Whole animal section in situ hybridization and protein blotting: new tools in molecular analysis of animal models for human disease. (1989) (17)
Arenaviruses. II. The molecular pathogenesis of arenavirus infections. Introduction. (2002) (17)
The role of proteolytic processing and the stable signal peptide in expression of the Old World arenavirus envelope glycoprotein ectodomain. (2013) (17)
Is the TAM Receptor Axl a Receptor for Lymphocytic Choriomeningitis Virus? (2013) (17)
Lymphocytic choriomeningitis virus can persistently infect thyroid epithelial cells and perturb thyroid hormone production. (1987) (17)
Dissecting the molecular anatomy of the nervous system: Analysis of RNA and protein expression in whole body sections of laboratory animals (1986) (17)
Polymorphism of cytotoxic T-lymphocyte clones that recognize a defined nine-amino-acid immunodominant domain of lymphocytic choriomeningitis virus glycoprotein (1989) (17)
Susceptibility of newborn mice with H-2k backgrounds to lymphocytic choriomeningitis virus infection. (1980) (17)
Viral persistent infection affects both transcriptional and posttranscriptional regulation of neuron-specific molecule GAP43. (1997) (16)
Role of viral strains and host genes in determining levels of immune complexes in a model system: implications for HIV infection. (1991) (16)
The epidemiology, molecular and cell biology of arenaviruses (2002) (16)
Disease model: dissecting the pathogenesis of the measles virus. (2001) (16)
Animal virus pathogenesis. A practical approach. (1990) (16)
Scrapie-Induced Defects in Learning and Memory of Transgenic Mice Expressing Anchorless Prion Protein Are Associated with Alterations in the Gamma Aminobutyric Acid-Ergic Pathway (2008) (15)
Mapping of the major histocompatibility complex and viral antigens on the plasma membrane of a measles virus-infected cell. (1983) (15)
Virus-neuron-cytotoxic T lymphocyte interactions. (1995) (15)
Specificity of in vitro cytotoxic T cell clones directed against vesicular stomatitis virus. (1983) (15)
Relationship between major histocompatibility antigens and disease. Possible associations with human arenavirus diseases. (1975) (15)
Virus-induced autoimmune disease: transgenic approach to mimic insulin-dependent diabetes mellitus and multiple sclerosis. (1996) (15)
Replication of lymphocytic choriomeningitis virus is restricted in terminally differentiated neurons (1993) (15)
Custom-designed synthetic peptide immunoassays for distinguishing HIV type 1 and type 2 infections. (1989) (14)
Direct immunofluorescent tissue culture assay for lymphocytic choriomeningitis virus. (1968) (14)
Persistent infection with lymphocytic choriomeningitis virus enhances expression of MHC class I glycoprotein on cultured mouse brain endothelial cells. (1991) (14)
Disruption of differentiated functions during viral infection in vivo. V. Mapping of a locus involved in susceptibility of mice to growth hormone deficiency due to persistent lymphocytic choriomeningitis virus infection. (2001) (14)
Autoimmunity and viruses--fact or fiction: persistent LCM viral infection, anti-LCM viral immune response, and tissue injury. (1971) (14)
Mouse liver-specific CD8(+) T-cells encounter their cognate antigen and acquire capacity to destroy target hepatocytes. (2013) (14)
Histocompatibility Complex and Virus Infection Latency and Activation (1976) (14)
VIRUS INDUCED AUTOIMMUNE DISEASE: VIRUSES IN THE PRODUCTION AND PREVENTION OF AUTOIMMUNE DISEASE (1972) (14)
Viruses and Autoimmune Diseases (1997) (14)
Pathogenesis of immune complex glomerulonephritis of New Zealand mice. (1971) (13)
Electron microscopy of an alpha-dystroglycan fragment containing receptor sites for lymphocytic choriomeningitis virus and laminin, and use of the receptoid body as a reagent to neutralize virus. (2004) (13)
Natural killer cell activity in patients with multiple sclerosis given alpha interferon. (1983) (13)
Influenza NS1 directly modulates Hedgehog signaling during infection (2017) (13)
Cytotoxic lymphocytes generated in vivo with acute measles virus infection. (1985) (13)
Dendritic cell inhibition: memoirs from immunosuppressive viruses. (2006) (13)
Morphologic analysis of the interactions between lymphocytic choriomeningitis virus-specific cloned cytotoxic T cells and virus infected targets. (1987) (13)
Killing of virus-infected cells: the role of antiviral antibody and complement in limiting virus infection. (1980) (12)
Limiting the available T cell receptor repertoire modifies acute lymphocytic choriomeningitis virus-induced immunopathology (1994) (12)
Immunopathology of adoptive immunization in mice chronically infected with lymphocytic choriomeningitis virus. (1977) (12)
Expression of selected antigens on the surface of cultured neural cells. (1974) (12)
Immunopathology of persistent viral infections. (1982) (12)
Perturbation of differentiated functions during viral infection in vivo. In vivo relationship of host genes and lymphocytic choriomeningitis virus to growth hormone deficiency. (1990) (11)
Human cytomegalovirus in the pancreas of patients with type 2 diabetes: Is there a relation to clinical features, mRNA and protein expression of insulin, somatostatin, and MHC class II? (2005) (11)
Molecular anatomy of viral disease (1987) (11)
Lupus acceleration by a MAVS-activating RNA virus requires endosomal TLR signaling and host genetic predisposition (2018) (11)
In vitro detection of cells infected with lactic dehydrogenase virus (LDV) by fluorescein-labeled antibody to LDV. (1974) (11)
Reoviruses II. Cytopathogenicity and pathogenesis. (1998) (11)
Alpha-dystroglycan can mediate arenavirus infection in the absence of beta-dystroglycan. (2003) (11)
Virus‐induced autoimmune disease: transgenic approach to mimic insulin‐dependent diabetes mellitus and other autoimmune diseases: (1996) (10)
Change in susceptibility of C3H-HeJ mice to LCM virus infection. (1973) (10)
A Jekyll and Hyde Profile: Type 1 Interferon Signaling Plays a Prominent Role in the Initiation and Maintenance of a Persistent Virus Infection. (2015) (10)
Changes in the cytoplasmic structure of CTLs during target cell recognition and killing. (1996) (10)
Is activation of autoreactive lymphocytes always detrimental? Viral infections and regulatory circuits in autoimmunity. (2001) (10)
Ebola-Specific CD8+ and CD4+ T Cell Responses in Sierra Leonean Ebola Virus Survivors with and without Post Viral Sequelae. (2020) (10)
Virus-induced immune-complex-type glomerulonephritis. (1969) (10)
State of viral genome and proteins during persistent lymphocytic choriomeningitis virus infection. (1987) (10)
An old nemesis in new clothing: viruses playing new tricks by causing cytopathology in the absence of cytolysis. (1985) (10)
A transgenic mouse model to assess the interaction of cytotoxic T lymphocytes with virally infected, class I MHC-expressing astrocytes (1994) (10)
Molecular pathogenesis of arenavirus infections (1986) (10)
Immune complex disease in chronic viral infections. (1971) (10)
Virologic models of chronic relapsing demyelinating disease. (1983) (9)
Identification of Common CD8+ T Cell Epitopes from Lassa Fever Survivors in Nigeria and Sierra Leone (2020) (9)
The Failure of Monoclonal Antibody‐defined Lymphocyte Subsets to Monitor Disease Activity in Patients with Multiple Sclerosis a (1984) (9)
TUBULAR PARTICLES IN A CASE OF RECURRENT LYMPHOCYTIC MENINGITIS FOLLOWED BY AMYOTROPHIC LATERAL SCLEROSIS (1975) (9)
Subversion of the immune system by measles virus: a model for the intricate interplay between a virus and the human immune system. (2006) (9)
Cytotoxic T-Lymphocytes in Human Viral and Malaria Infections (1994) (9)
Novel LCMV-specific H-2k restricted CTL clones recognize internal viral gene products and cause CNS disease (1992) (9)
Aging and chronic virus infection: is there a relationship? (1974) (9)
Mutation of the ER retention receptor KDELR1 leads to cell-intrinsic lymphopenia and a failure to control chronic viral infection (2015) (9)
The M22 antibody identifies highly activated reactive astrocytes responding to central nervous system disease (1996) (9)
Adenovirus E3 MHC inhibitory genes but not TNF/Fas apoptotic inhibitory genes expressed in β cells prevent autoimmune diabetes (2009) (9)
Extraneural manifestations of prion infection in GPI-anchorless transgenic mice. (2011) (8)
Measles virus fusion shifts into gear (2011) (8)
Immunobiology of Natural Killer Cell Receptors (2006) (8)
Altered Reactivity to Escherichia coli Endotoxin of Mice Subjected to Sub-Lethal Tourniquet Treatment (1959) (8)
Infection and involution of mouse thymus by MHV-4. (1987) (8)
Virology in the Next Millennium (2000) (8)
Travels along the viral–immunobiology highway (2002) (8)
Release of macrophage migration inhibitory factor by virus-infected spleen cells. (1971) (8)
Generation of a functional cDNA encoding the LdH2 class-I molecule by using a single-LTR retroviral shuttle vector. (1991) (8)
Host and virus factors associated with CNS cellular tropism leading to encephalomyelitis or demyelination induced by the JHM strain of mouse hepatitis virus. (1981) (8)
The arenaviruses--an introduction. (1987) (8)
HIV and Dementia (1995) (8)
Functional Glycosylation of Dystroglycan Is Crucial for Thymocyte Development in the Mouse (2010) (8)
Cytotoxic T lymphocytes do not control lymphocytic choriomeningitis virus infection of BB diabetes-prone rats. (1990) (8)
Probe Development Efforts to Identify Novel Antagonists of the Sphingosine 1-phosphate Receptor 4 (S1P4) (2010) (7)
Evidence against pyridoxine deficiency as the mechanism of penicillin seizures (1969) (7)
Retrovirus Infections of the Nervous System (1990) (7)
The use of lymphocytic choriomeningitis virus reassortants to map viral genes causing virulence (2005) (7)
Immunopathologic Disease of the Central Nervous System (1982) (7)
Myasthenia gravis: in vitro immunoglobulin production with pokeweed mitogen challenge and B- and T-lymphocyte competence. (1981) (7)
High Constitutive Interleukin 10 Level Interferes With the Immune Response to Varicella-Zoster Virus in Elderly Recipients of Live Attenuated Zoster Vaccine (2018) (7)
LYMPHOCYTE FUNCTIONS: Selected Principles Characterizing Virus- Induced Immunosu ppression (1987) (7)
Molecular Mimicry and Autoimmunity (1986) (7)
Lymphocyte-mediated cytotoxicity to measles virus in patients with multiple sclerosis. (1979) (6)
Lack of Prion Infectivity in Fixed Heart Tissue from Patients with Creutzfeldt-Jakob Disease or Amyloid Heart Disease (2013) (6)
CD8+ T-Cell Epitope Mapping for Pneumonia Virus of Mice in H-2b Mice (2013) (6)
Arenaviruses: biology and immunotherapy. (1987) (6)
Inhibition of diabetes in BB rats by virus infection. II. Effect of virus infection on the immune response to non-viral and viral antigens. (1990) (6)
Endocrinological Aspects of Benign Intracranial Hypertension (1966) (6)
Identification of a Novel Agonist of the Sphingosine 1-phosphate Receptor 4 (S1P4) (2010) (6)
STUDIES ON THE MOLECULAR BIOLOGY OF LYMPHOCYTIC CHORIOMENINGITIS VIRUS (1984) (6)
Weight loss in obese mice persistently infected with lymphocytic choriomeningitis virus is not associated with elevated tumor necrosis factor/cachectin activity in peritoneal macrophages. (1988) (6)
Studies on rickettsial toxins. V. Dissimilarity between the action of rickettsial mouse lethal toxin and bacterial endotoxin in mice. (1961) (5)
Sphingosine-1-Phosphate Signaling in Immunology and Infectious Diseases (2014) (5)
HIV-1 Latency (2018) (5)
Oncogenes and Retroviruses (1989) (5)
Arenaviruses: genes, proteins, and expression. (1987) (5)
In Situ Hybridization (1989) (5)
Immune complex deposits in the choroid plexus. (1978) (5)
The riddle of the Sphinx: why sphingosine‐1‐phosphate may help define molecular mechanisms underlying risk stratification for serious COVID‐19 infections (2020) (5)
Immunoglobulin deposits in amyotrophic lateral sclerosis. (1973) (5)
Analysis of endogenous and exogenous antigens in the nervous system using whole animal sections (1986) (5)
Complement-Dependent Lysis of RNA Tumor Viruses (1976) (5)
Molecular basis of viral persistence. (1987) (5)
Microbial subversion of immunity: current topics (2006) (5)
Antibody mediated complement dependent lysis of virus infected cells (2004) (5)
Viruses and the kidney. (1974) (5)
CD4+CD25+ regulatory T cells : origin, function and therapeutic potential (2005) (5)
Lymphocytic Choriomeningitis Virus Alters the Expression of Male Mouse Scent Proteins (2021) (4)
Lymphocytic choriomeningitis: an animal model of persistent viral infection with cellular injury mediated by host antiviral immune response. (1971) (4)
Thymus-Dependent (T) Cell Competence in Chronic LCM Virus Infection (1973) (4)
Potential pathogenic mechanisms of injury in amyotrophic lateral sclerosis. (1976) (4)
Pathology of the choroid plexus in spontaneous immune complex disease and chronic viral infections (1974) (4)
Acute and Recurrent Demyelination Induced by Wild-Type and Temperature-Sensitive Mutants of Mouse Hepatitis Virus. Electron-Microscopic Studies (1980) (4)
Influenza pathogenesis and control (2014) (4)
Infectious Diseases Society of America. Trials of interferon therapy for multiple sclerosis. (1982) (4)
Viral persistence and immune dysfunction. (1990) (4)
Early events in allergic encephalomyelitis. (1968) (4)
Viruses can cause disease in the absence of morphologic evidence of cell injury: pathology in the absence of cell lysis--implication for pathologists' future study of disease. (1990) (3)
Analysis of lymphocytic choriomeningitis virus gene expression in acutely and persistently infected mice (1986) (3)
Persistent Lymphocytic Choriomeningitis Viral Infection (1970) (3)
Manufacture of a functional cDNA for the H-2Db molecule using a retroviral shuttle vector (2004) (3)
Immune balance in the cytomegalovirus-infected host: in vitro studies of virus-lymphocyte interactions and the effects on specific lymphocyte function. (1984) (3)
Reply to Matthaei et al.: The p150 isoform of the RNA editing enzyme Adenosine Deaminase 1 is required for embryogenesis (2011) (3)
The immunological response of lcm viral carrier mice and associated pathologic changes. Abstr. (1968) (3)
Cell biology of virus entry, replication and pathogenesis (1992) (3)
RESTRICTED MOBILITY OF INFLUENZA HEMAGGLUTININ ON HELA CELL PLASMA MEMBRANES (1984) (3)
B cell–derived IL-27 promotes control of persistent LCMV infection (2022) (3)
Molecular Anatomy of the Cytotoxic T-Lymphocyte Responses to Lymphocytic Choriomeningitis Virus (1993) (3)
Mucosal Vaccines (2012) (3)
Distortion of cell functions by noncytotoxic viruses. (1986) (3)
An Odyssey to Viral Pathogenesis. (2016) (2)
FineMappingofan Immunodominant Domaininthe Transmembrane Glycoprotein ofHumanImmunodeficiency Virust (1987) (2)
ANTIBODY-INDUCED MODULATION OF VIRAL ANTIGENS FROM INFECTED CELLS: BIOLOGICAL AND MOLECULAR STUDIES OF MEASLES VIRUS INFECTION AND IMPLICATIONS FOR UNDERSTANDING VIRUS PERSISTENCE AND RECEPTOR DISEASES (1980) (2)
The game's afoot: seeking viruses that cause chronic and degenerative neurologic and psychiatric disorder (2012) (2)
Frank J. Dixon 1920–2008 (2008) (2)
Generation of virus-specific cytolytic activity in human peripheral lymphocytes after vaccination with vaccinia virus and measles virus (1978) (2)
PATHOGENESIS OF AIDS ENCEPHALITIS: 48 (1987) (2)
68 IMMUNOLABELING STUDIES OF MOUSE SPINAL CORD INFECTED WITH MOUSE HEPATITIS VIRUS (1980) (2)
HIV neurons and cytotoxic T lymphocytes. Concepts about the AIDS dementia complex and viral persistence. (1994) (2)
Future trends in neurovirology: Neuronal survival during virus infection and analysis of virus-specific T cells in central nervous system tissues (2011) (2)
A unique variant of lymphocytic choriomeningitis virus that induces pheromone binding protein MUP: Critical role for CTL (2019) (2)
The anatomy of viral persistence (1992) (2)
Interactions Between Viruses and Lymphocytes (1978) (2)
Arenaviruses II (2002) (2)
Prevention of CD8 T Cell Deletion during Chronic Viral Infection (2021) (2)
Differential effects of MHV-4 infection of astrocytes and oligodendrocytes in vitro. (1987) (2)
VIRUS-INDUCED DEMYELINATION BY MHV-4 ts8: VIRUS ANTIGEN LOCALIZATION IN OLIGO-DENDROCYTES AND THEIR MYELIN SHEATHS (1982) (2)
Reply to Steinman and Wang: Involvement of the p150 isoform of the RNA editing enzyme ADAR1 in embryonic lethality (2011) (1)
Dissecting the molecular anatomy of persistent infection with lymphocytic choriomeningitis virus (1986) (1)
The signal sequence of lymphocytic choriomeningitis virus contains an immuno-dominant CD8+ cytotoxic T cell epitope that is restricted by both H-2Db and H-2Kb molecules (1997) (1)
MECHANISM OF PERSISTENT LCMV INFECTION IN MICE: ROLE OF LCMV VARIANTS IN SUPPRESSION OF LCMV SPECIFIC CYTOTOXIC T CELL RESPONSE AND MAINTENANCE OF THE CARRIER STATE (1984) (1)
Molecular and topographic analysis of the glycoproteins of lymphocytic choriomeningitis virus (LCMV) (1985) (1)
Studies on Rickettsial Toxins (1954) (1)
Endothelial dysfunction in the pathogenesis of acute Lassa Fever (2018) (1)
The arenaviruses--an introduction. (1987) (1)
The immune response of mice persistently infected with lcm virus to non-viral antigens. Abstr. (1970) (1)
A neurologist looks at (to) the kidney. (1969) (1)
Perturbation of endocrine functions during persistent infection of mice with lymphocytic choriomeningitis virus (2005) (1)
The molecular pathogenesis of arenavirus infectious (2002) (1)
Gene cloning in organisms other than E. coli. (1982) (1)
H-2 linked genetic control of disease susceptibility, murine lymphocytic choriomeningitis (lcm) virus infection. Abstr. (1973) (1)
Immunologic Injury in Measles Virus Infection (1977) (1)
Dysfunctional Platelet Aggregation in Patients with Acute Lassa Fever (2017) (1)
Reoviruses I (1998) (1)
14 PERIPHERAL NEUROPATHY IN EXPERIMENTAL MACROGLOBULINEMIA (1981) (1)
HIV and dementia. Proceedings of the NIMH-sponsored conference "Pathogenesis of HIV Infection of the Brain: Impact on Function and Behavior". April 4-7, 1994, Chantilly, Virginia. (1995) (1)
Failure to isolate a transmissible agent from the bone-marrow of patients with multiple sclerosis. (1979) (1)
Cytopathogenicity and pathogenesis (1998) (1)
CROSS-REACTION OF MEASLES VIRUS PHOSPHOPROTEIN WITH A HUMAN INTERMEDIATE FILAMENT: MOLECULAR MIMICRY DURING VIRUS INFECTION1 (1984) (1)
COAGULATION FACTORS IN THE CNS: EXPRESSION AND SIGNIFICANCE OF TISSUE FACTOR (1993) (1)
C Dependent Immune Lysis of Virus Altered Plasma Membranes: Dependence on the Alternative C Pathway and Factor B (1976) (1)
Structure, proteins, and genetics (1998) (1)
Microbial Subversion of Immunity (2007) (1)
Using synthetic peptide reagents to distinguish infections caused by different HIV strains. (1990) (1)
Immune to the facts (2004) (1)
Measles Virus Captures Specific Host Machineries to Cause Immunosuppression and Disease (2009) (1)
Molecular and topographic analysis of the glycoproteins of lymphocytic choriomeningitis virus (1986) (1)
Molecular Anatomy of Viral Infection: Study of Viral Nucleic Acid Sequences and Proteins in Whole Body Sections (1986) (1)
A passion for DNA: genes, genomes and society (2001) (1)
Antigen Recognition by Cytotoxic T Cells (1989) (1)
Immunologic Derangements Caused by Chronic Viral Infections (1971) (1)
The role of antibody and complement in lysing virus-infected cells (2005) (1)
The endocrinological aspects of benign intracranial hypeertension. (1966) (0)
Viral subversion of humoral immune responses. (2006) (0)
Figure 2, LC-MS results for ML248 (2010) (0)
Table 2, Selected S1P4 Receptor Agonists from the Primary Screening Campaign (2011) (0)
Hepatitis Viruses: Oysters, Blood Transfusions, and Cancer (2020) (0)
Table 4, SAR Table for S1P4 Receptor Agonist Probe Optimization. Fragment point of attachment of is indicated with an * (2011) (0)
Molecular studies of lymphocytic choriomeningitis virus infections (1985) (0)
The differential spread of prion strains into the brain (153.1) (2014) (0)
In memoriam: Hilary Koprowski: a Renaissance scientist. (2013) (0)
Diseases of Aging: Viral Genes and Perturbation of Differentiated Functions in Persistent Infection (1985) (0)
HISTOCOMPATIBILI TY-LINKED G ENETIC CONTROL OF DISEASE S USCEPTIBILITY (1973) (0)
Pathogenic H1N1 2009 influenza virus-induced pulmonary injury is suppressed by sphingosine analog-mediated inhibition of cytokine storm (49.3) (2011) (0)
Type I interferon signaling is essential for cytotoxic T lymphocytes to infiltrate into the pancreatic islet and cause type I diabetes (2016) (0)
Introduction to the Principles of Virology (2020) (0)
Figure 4, Dose response curve for probe ML131 assayed against the S1P4 receptor (2010) (0)
Proteins of Human Immunodeficiency Virus That Cross-React with Human Self Antigens (1991) (0)
Protein Structure and Biology (2013) (0)
CHAPTER 22 – PRINCIPLES OF IMMUNOBIOLOGY LEARNED FROM INVESTIGATION OF LYMPHOCYTIC CHORIOMENINGITIS VIRUS AND THE INFECTION IT PRODUCES (1986) (0)
Introduction to the Principles of Immunology (2020) (0)
Molecular mimiicry in virus infection : Crossreaction of measles virus phosphoprotein or of herpes simplex virus protein with human intermediate filaments ( monoclonal antibodies / vimentin / autoantibodies ) (0)
Mucosal innate immune response. (2006) (0)
protein production, antibody production and in vivo assessment of (2011) (0)
IN V I T R O GENERATION OF HUMAN C Y T O T O X IC LYMPHOCYTES BY VIRUS Viral Glycoproteins Induce Nonspecific Cell-mediated Cytotoxicity without Release of Interferon* (2003) (0)
Involvement of type I IFN signaling in lymphocyte migration and lymphoid structure during viral infection (P6306) (2013) (0)
Herpes simplex virus is associated with peptic ulcer disease. (1989) (0)
A method for the detection of cytomegalovirus (1986) (0)
Inhibiting the Inflammatory Response Following Influenza Virus Infection utilizing Sphingosine-1-phosphate receptor 1 signaling (92.4) (2010) (0)
Early events dependent on the suppression of IPS signaling are necessary for persistent viral infection (P6300) (2013) (0)
Chronic viral infection and antinuclear antibody in new zealand mice. Abstr. (1970) (0)
Memory T cell responses in survivors of the 2013–2016 West African Ebola outbreak (2018) (0)
Bruce Chesebro SpleenExpression in Peripheral Nerves and Administration : Role of Prion Protein following Oral or Intraperitoneal Scrapie Entry versus Blockade of Brain Infection (1999) (0)
HHV-4 INFECTION OF PRIMARY CULTURES OF MOUSE OLIGODENDROCYTES (1985) (0)
Figure 1, 1H NMR spectrum of probe ML178 (2011) (0)
TREATMENT WITH A SPHINGOSINE ANALOG DIMINSHES IMMUNOPATHOLOGY FOLLOWING INFLUENZA VIRUS INFECTION (45.2) (2009) (0)
The Anatomy of a Career in Science. (2016) (0)
Abstract 5743: Reprogramming myeloid cells by JAK inhibition to enhance checkpoint blockade immunotherapy (2023) (0)
Biological and genomic variability among arenaviruses (2018) (0)
Figure 3, Stability of probe ML248 in PBS (2010) (0)
Inhibition of Cellular Entry and Spread of Lymphocytic Choriomeningitis Virus by Amphipathic DNA Polymers (2007) (0)
Altered Antiviral T Cell Hierarchy Cells During Negative Selection Results in an T + Preferential Escape of Subdominant CD 8 (2003) (0)
Cytomegalovirus in the pancreas of patients with type 2 non insulin dependent diabetes mellitus is there a role for a viral etiology (1990) (0)
Phenotypic small-molecule screening identifies JAK inhibitors as pharmacologic modulators of T cell exhaustion (2020) (0)
Clearance of viral nucleic acid sequences from persistently infected host by virus specific H-2 restricted lymphocytes (1985) (0)
Mapping viral genes which determine suppression of the cytotoxic T-cell response (1988) (0)
B7-1 expression enhances virus-induced CNS autoimmune disease (1998) (0)
Lymphocytes Specific for Lymphocytic Choriomeningitis Virus: Clearance of Virus (0)
Microbial Subversion of NK cell Function (2006) (0)
Treatment of virus-induced autoimmune diabetes by oral administration of insulin: Study on the mechanism by which oral antigens can abrogate autoimmunity (2009) (0)
Defined Nine-Amino-Acid Immunodominant Domain of Lymphocytic Choriomeningitis Virus Glycoproteint (2003) (0)
LCMV-specific CTL and Antibody Responses During Acute and Persistent LCMV Infection (2003) (0)
Table 1, Probe Properties for ML131 (2010) (0)
Expanded potential for recombinant tri-segmented LCM viruses: 1 protein production, antibody production and in vivo assessment of 2 biological function of genes of interest (2011) (0)
S-7: Lindenmann looked for a herring and found a smallmouth bass. We looked for Dr. Jekyll and found Mr. Hyde: Interferon induces persistent viral infection (2013) (0)
The generation of proteases by reactive astrocytes (1995) (0)
Culture costs lives (2007) (0)
Table 6, Selectivity of selected S1P4 receptor agonist compounds against S1P1, S1P2, S1P3, and S1P5 (2010) (0)
Mono clonal antibodies to mouse hepatitis virus jhm their ability to inhibit biological activities of the virus (1982) (0)
Microbe hunters, then and now (1996) (0)
Reevaluating HLA-A2-restricted Lassa epitopes in human Lassa fever survivors (2020) (0)
Profile of Michael B. A. Oldstone. Interview by Nicholette Zeliadt. (2013) (0)
Airway Delivery of a Sphingosine Analog Disrupts Antigen Presentation and Inhibits Virus-Specific CD8+T Cell Expansion While Sparing Generation of Protective Antibodies after Influenza Virus Infection. (2009) (0)
128 ANTIBODY MEDIATED INJURY TO VIRUSES AND VIRUS INFECTED CELLS (1980) (0)
Table 1, Published S1P4 receptor agonists (2011) (0)
Table 7, Molecular weight and physiochemical properties for ML248 and analogs 1–5 (2010) (0)
Myeloid reprogramming by JAK inhibition enhances checkpoint blockade therapy (2022) (0)
Table 3, SAR Table for S1P4 receptor antagonist probe optimization (2010) (0)
Virus induced suppression of immunoglobulin synthesis during measles virus infection due to a direct defect of B lymphocytes (1985) (0)
T Cells Inﬁltrate the Brain in Murine and Human Transmissible Spongiform Encephalopathies† (2003) (0)
Diagnosis of AIDS Using Designed Amino Acid Peptides Representing Immunodominant Epitopes of HIV (1990) (0)
Molecular insights into infections of the central nervous system. (1990) (0)
Transforming proteins of DNA tumor viruses (1989) (0)
Maintaining Immunity: A Tale of Two T Cell Populations (2002) (0)
Correction (1989) (0)
The Two Faces of the Cytotoxic Lymphocyte (2004) (0)
Cytotoxic t cells generated with laboratory strain ad 169 and fresh isolates of cytomegalovirus (1985) (0)
Current Topics in Microbiology and Immunology 129 (1986) (0)
B-cell survival in mouse models of allotransplantation and autoimmunity mediated by adenovirus immunomodulatory genes (2009) (0)
USE OF THE MURINE GLIAL FIBRILLARY ACIDIC PROTEIN (GFAP) GENE TO TARGET EXPRESSION OF HYBRID GENES TO THE CNS: ASTROCYTE SPECIFIC EXPRESSION IN TRANSGENIC MICE (1990) (0)
Figure 5, S1P4 agonist HTS overview (2010) (0)
A CD 4 + cytotoxic T-lymphocyte clone to a conserved epitope on human immunodeficiency virus type 1 p 24 : cytotoxic activity and secretion of interleukin-2 and interleukin-6 (2017) (0)
Expansion of CD8+ T cell population in Lassa virus survivors with low T cell precursor frequency reveals durable immune response in most survivors (2022) (0)
IL-10 blockade resurrects T cell activity and eliminates a persistent viral infection (46.3) (2007) (0)
Autoimmune Diabetes Can Be Induced In Transgenic Major Histocompatibility Complex Class H-deficient Mice By Terri M. Laufer,*~ Matthias G. yon Herrath,$ (1993) (0)
Antiovalbumin Immune Response Recombinant Artificial APC : Following the T Cells Using + Detection of Low-Avidity CD 4 (2002) (0)
Subject Index, Vol. 35, 1993 (1993) (0)
MiR-17~92 family microRNAs are critical regulators of T follicular helper cell differentiation (P1133) (2013) (0)
Enzyme Linked Immunosorbent Assays ( ELISAs ) for Measurement of Antiviral Antibody Levels (2003) (0)
Chronic Virus Infection and Immune Responsiveness (1974) (0)
Characterizations of the virus‐induced differentiation of bone marrow plasmacytoid dendritic cells into CD11b+ dendritic cells (2008) (0)
ULTRASTRUCTURAL LOCALIZATION OF VIRAL ANTIGEN IN MICE PERSISTENTLY INFECTED WITH LYMPHOCYTIC CHORIOMENINGITIS VIRUS (LCMV): 77 (1982) (0)
Aminobutyric Acid-Ergic Pathway with Alterations in the Gamma Anchorless Prion Protein Are Associated Memory of Transgenic Mice Expressing Scrapie-Induced Defects in Learning and (2014) (0)
The Antibody Response of Mice to Murinc Infection: Absence of Classical Immunoll (AKR mice/complement-fixing antibodies/lymnphocytic c) immu nofluorescence/glomerular deposits of antigen-anti (2016) (0)
Viral immune evasion: an overview. (2006) (0)
Table 2, Potency and selectivity of lead scaffolds from HTS screen (2010) (0)
Table 2, Overview of PubChem assays for S1P4 agonist project (2010) (0)
A comparison ofbiochemical andbiological properties ofstandard anddefective lymphocytic choriomemnngitis virus (1975) (0)
Retrovirus Infections of the Nervous System: Current and Future Perspectives (1990) (0)
MT Mice μ MT / μ with Virus-Specific Memory Cells from Infection after Adoptive Immunotherapy Mice : Failure To Clear Persistent Virus and CD 8 T-Cell Defect in B-Cell-Deficient Evidence for an Underlying CD 4 Helper (1998) (0)
DEFECTIVE-INTERFERING VIRUS CAN PREVENT LCM VIRUS INDUCED CEREBELLAR NECROSIS: 85 (1976) (0)
Lassa Fever (2020) (0)
Figure 2, LC-MS results for probe ML178 (2011) (0)
Human Immunodeficiency Virus: AIDS, the Current Plague (2020) (0)
An Overview of Newly Emerging Viral Plagues: The Hemorrhagic Fevers and a Newly Mysterious Suspect of Viral Disease, Acute Flaccid Paralysis (2020) (0)
Molecular AnatomyofViral Persistencet (1991) (0)
Figure 6, Dose response curve for ML248 (2010) (0)
Table 8, Targets that exhibited ≥ 50% inhibiton in Ricerca screening (2010) (0)
Reversing T cell Exhaustion Through Discovery of Small Molecules (2018) (0)
Evasion mechanisms of bacteria. (2006) (0)
Identification of a novel cytokine amplification loop during influenza infection (P6142) (2013) (0)
Table 3, Specificity of selected S1P4 receptor agonist compounds against S1P1, S1P2, S1P3, and S1P5 receptors (2011) (0)
Subversion of complement. (2006) (0)
Mapping and altering lymphocytic choriomeningitis viral gene expression during persistent infection (1985) (0)
Figure 1, Potential nuclear Overhauser effects in ML248 (2010) (0)
Designing Peptides to Immunologically Distinguish Specific Human Immunodeficiency Virus Isolates (1989) (0)
Diabetes Development AcceleratesSpontaneous Islet Infiltration and Islet-Specific Expression of CXCL 10 Causes and (2005) (0)
Figure 1, LC-MS results for probe ML131 (2010) (0)
MHC expression in CNS cells in vivo and the biologic consequences (1998) (0)
Is Herpes Simplex Virus Associated with Peptic Ulcer Disease ? t (0)
Viral diseases of the next century. (1994) (0)
Virology in the Next Millennium Minireview (2000) (0)
Viruses and dendritic cells: a prominent mechanism for subverting the immune response. (2006) (0)
Hantavirus (2020) (0)
IN VIVO EXPRESSION OF PERFORIN BY CD8+ LYMPHOCYTES DURING AN ACUTE VIRAL INFECTION BY LUCY (2003) (0)
Correction (1986) (0)

This paper list is powered by the following services:

What Schools Are Affiliated With Michael B. A. Oldstone?

Michael B. A. Oldstone is affiliated with the following schools:

Michael B. A. Oldstone's Academic­Influence.com Rankings

Why Is Michael B. A. Oldstone Influential?

Michael B. A. Oldstone's Published Works

Published Works

What Schools Are Affiliated With Michael B. A. Oldstone?

Michael B. A. Oldstone's AcademicInfluence.com Rankings